91940-85-1 Usage
Uses
Used in Pharmaceutical Industry:
2-Isobutylisonicotinic acid is utilized as a therapeutic agent for the treatment of diabetic peripheral neuropathy and other neurological disorders. It is used for its potential to improve nerve function and reduce pain associated with nerve damage, offering a promising avenue for managing these conditions.
Used in Research and Development:
In the field of research and development, 2-Isobutylisonicotinic acid is employed as a subject for further studies to explore its potential uses and mechanisms of action. This includes understanding its effects on nerve function and pain reduction, as well as identifying any additional therapeutic applications that may benefit from its unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 91940-85-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,9,4 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 91940-85:
(7*9)+(6*1)+(5*9)+(4*4)+(3*0)+(2*8)+(1*5)=151
151 % 10 = 1
So 91940-85-1 is a valid CAS Registry Number.
91940-85-1Relevant academic research and scientific papers
PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
-
Page/Page column 13, (2011/09/20)
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims.
PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
-
Page/Page column 35-36, (2009/04/25)
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituants are as defined in the claims.
Novel scaffolds for beta-helix mimicry
-
Page/Page column 32, (2008/06/13)
Functionalized pyridazine derivatives having a low molecular weight and pharmaceutical compositions thereof are useful as alpha-helix mimetics and for treating conditions and/or disorders mediated by alpha-helix-binding receptors and proteins.
